HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong
· Delayed Price · Currency is HKD 2.910
-0.040 (-1.36%)
May 20, 2025, 4:08 PM HKT
HighTide Therapeutics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 310.75 | 608.21 | 412.34 | 765.29 |
| Short-Term Investments | - | 0.68 | 428.26 | 0.5 |
| Trading Asset Securities | 179.77 | 127.49 | - | - |
| Cash & Short-Term Investments | 490.52 | 736.38 | 840.6 | 765.79 |
| Cash Growth | -33.39% | -12.40% | 9.77% | - |
| Other Receivables | 0.57 | 16.31 | 2.34 | 3.64 |
| Receivables | 0.57 | 16.31 | 2.34 | 3.64 |
| Other Current Assets | 22.28 | 26.07 | 8.08 | 5.75 |
| Total Current Assets | 513.37 | 778.75 | 851.02 | 775.18 |
| Property, Plant & Equipment | 23.89 | 14.98 | 4.81 | 3.45 |
| Long-Term Investments | 21.09 | - | - | - |
| Other Long-Term Assets | 1.58 | 1.3 | - | - |
| Total Assets | 559.93 | 795.04 | 855.82 | 778.63 |
| Accounts Payable | 51.47 | 30.51 | 21.7 | 6.09 |
| Accrued Expenses | - | 40.68 | 23.55 | 14.75 |
| Short-Term Debt | 46.93 | 3.5 | 8.15 | 7 |
| Current Portion of Long-Term Debt | - | - | 1,260 | - |
| Current Portion of Leases | 5.49 | 2.47 | 1.11 | 0.25 |
| Current Income Taxes Payable | - | 0.38 | 0.31 | 0.23 |
| Current Unearned Revenue | - | 1.4 | 4.64 | - |
| Other Current Liabilities | 6.05 | 0.87 | 0.24 | 0.21 |
| Total Current Liabilities | 109.95 | 79.81 | 1,320 | 28.53 |
| Long-Term Debt | 9.96 | - | - | 1,006 |
| Long-Term Leases | 15.53 | 10.46 | 1.51 | 0.9 |
| Long-Term Unearned Revenue | 0.33 | 1.99 | 5.12 | 15.56 |
| Total Liabilities | 135.76 | 92.26 | 1,326 | 1,051 |
| Common Stock | 0.36 | 0.35 | 0.03 | 0.03 |
| Additional Paid-In Capital | - | 2,316 | 30.61 | 30.61 |
| Retained Earnings | - | -1,696 | -757.01 | -566.77 |
| Treasury Stock | -0.04 | -0.05 | -0.01 | -0 |
| Comprehensive Income & Other | 423.85 | 83.17 | 3.12 | 11.14 |
| Total Common Equity | 424.17 | 702.75 | -723.26 | -524.99 |
| Shareholders' Equity | 424.17 | 702.77 | -470.53 | -272.26 |
| Total Liabilities & Equity | 559.93 | 795.04 | 855.82 | 778.63 |
| Total Debt | 77.91 | 16.43 | 1,271 | 1,014 |
| Net Cash (Debt) | 412.62 | 719.94 | -430.19 | -248.27 |
| Net Cash Growth | -42.69% | - | - | - |
| Net Cash Per Share | 0.91 | 2.77 | -1.69 | -5.91 |
| Filing Date Shares Outstanding | 452.08 | 514.77 | 40.35 | 42.04 |
| Total Common Shares Outstanding | 452.08 | 514.77 | 40.35 | 42.04 |
| Working Capital | 403.43 | 698.94 | -468.7 | 746.65 |
| Book Value Per Share | 0.94 | 1.37 | -17.92 | -12.49 |
| Tangible Book Value | 424.17 | 702.75 | -723.26 | -524.99 |
| Tangible Book Value Per Share | 0.94 | 1.37 | -17.92 | -12.49 |
| Machinery | - | 6.09 | 5.29 | 5.11 |
| Leasehold Improvements | - | 0.27 | 0.27 | 0.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.